CollPlant Biotechnologies Shares Outstanding History (CLGN)
CollPlant Biotechnologies reported 12.8M shares outstanding at the end of fiscal 2025.
View full CollPlant Biotechnologies company overviewCollPlant Biotechnologies annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 12.8M | 1.3M | +11.77% |
| 2024 | 2024-12-31 | 11.5M | 1,840 | +0.02% |
| 2023 | 2023-12-31 | 11.5M | 266,191 | +2.38% |
| 2022 | 2022-12-31 | 11.2M | 414,457 | +3.85% |
| 2021 | 2021-12-31 | 10.8M | 3.8M | +54.69% |
| 2020 | 2020-12-31 | 7.0M | 1.3M | +22.80% |
| 2019 | 2019-12-31 | 5.7M | — | — |
CollPlant Biotechnologies quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 12.8M | 1.4M | +12.25% |
| Q4 2024 | 2024-12-31 | 11.5M | 268,031 | +2.40% |
| Q2 2024 | 2024-06-30 | 11.5M | 682,488 | +6.34% |
| Q4 2023 | 2023-12-31 | 11.5M | 680,648 | +6.32% |
| Q2 2023 | 2023-06-30 | 11.4M | 1.1M | +11.18% |
| Q4 2022 | 2022-12-31 | 11.2M | 4.2M | +60.64% |
| Q2 2022 | 2022-06-30 | 10.8M | 4.3M | +66.56% |
| Q4 2021 | 2021-12-31 | 10.8M | 5.1M | +89.96% |
| Q2 2021 | 2021-06-30 | 10.3M | — | — |
| Q4 2020 | 2020-12-31 | 7.0M | — | — |
| Q2 2020 | 2020-06-30 | 6.5M | — | — |
| Q4 2019 | 2019-12-31 | 5.7M | — | — |
CollPlant Biotechnologies shares outstanding trends
Over the last five reported fiscal years, CollPlant Biotechnologies's shares outstanding moved from 7.0M to 12.8M, a change of 5.8M. The latest reported quarter, Q4 2025, shows 12.8M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CollPlant Biotechnologies filings at SEC.gov ↗